Crocin Protects Against Retinal Ischemia–Reperfusion Injury via Regulating Sirt6-Mediated Nrf2/HO-1 Pathway in Rats
Authors:
Open Access
- 5 January 2026
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 67 (1) , 23
Abstract
Purpose: To examine if crocin protects retinal ganglion cells (RGCs) from retinal ischemia–reperfusion (RIR) injury by activating the Sirt6-mediated Nrf2/HO-1 signaling pathway. Methods: Primary RGCs were isolated and treated with crocin (8–12 µM) under oxygen and glucose deprivation/reperfusion (OGD/R) conditions, and rats received intraperitoneal crocin (10–50 mg/kg) after RIR induction. Cell viability, apoptosis, endoplasmic reticulum stress (ERS), inflammatory responses, and reactive oxygen species (ROS) levels were assessed using Cell Counting Kit-8 (CCK-8) assays, flow cytometry, 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) staining, western blotting, and quantitative reverse-transcription PCR (qRT-PCR). Sirt6 and Nrf2 were silenced via siRNA transfection, and the Nrf2 inhibitor ML385 was used in vivo to validate pathway involvement. Results: Crocin significantly improved RGC viability, reduced apoptosis, and attenuated ROS accumulation, ERS (GRP78, p-PERK, CHOP), and pro-inflammatory cytokine expression (TNF-α, IL-1β, IL-6) in OGD/R-treated cells and RIR-injured retinas. Mechanistically, crocin upregulated Sirt6 expression, promoted Nrf2 nuclear translocation, and enhanced HO-1 levels, activating the Sirt6–Nrf2/HO-1 axis. Silencing Sirt6 or Nrf2 abrogated the protective effects of crocin, whereas ML385 reversed crocin-mediated retinal protection in vivo, confirming Nrf2 as a downstream effector of Sirt6. Conclusions: Crocin protects RGCs against RIR injury through the Sirt6–Nrf2/HO-1 pathway, alleviating ERS, inflammation, apoptosis, and oxidative stress. These findings suggest that crocin may be a possible therapeutic agent for retinal ischemic diseases.Keywords
This publication has 42 references indexed in Scilit:
- Anti-cerebral ischemia reperfusion injury of polysaccharides: A review of the mechanismsBiomedicine & Pharmacotherapy, 2021
- Emerging roles of SIRT6 in human diseases and its modulatorsMedicinal Research Reviews, 2020
- Crocin ameliorates arsenic trioxide‑induced cardiotoxicity via Keap1-Nrf2/HO-1 pathway: Reducing oxidative stress, inflammation, and apoptosisBiomedicine & Pharmacotherapy, 2020
- Melatonin attenuates diabetic cardiomyopathy and reduces myocardial vulnerability to ischemia‐reperfusion injury by improving mitochondrial quality control: Role of SIRT6Journal of Pineal Research, 2020
- SIRT6 protects retinal ganglion cells against hydrogen peroxide-induced apoptosis and oxidative stress by promoting Nrf2/ARE signaling via inhibition of Bach1Chemico-Biological Interactions, 2019
- Targeting Nrf2/HO-1 signaling by crocin: Role in attenuation of AA-induced ulcerative colitis in ratsBiomedicine & Pharmacotherapy, 2019
- A comprehensive review on regulatory effects of crocin on ischemia/reperfusion injury in multiple organsBiomedicine & Pharmacotherapy, 2018
- Crocin protects retinal ganglion cells against H2O2-induced damage through the mitochondrial pathway and activation of NF-κBInternational Journal of Molecular Medicine, 2015
- Crocin and quercetin prevent PAT-induced apoptosis in mammalian cells: Involvement of ROS-mediated ER stress pathwayEnvironmental Toxicology, 2015
- Protective Effect of Crocin against Blue Light– and White Light–Mediated Photoreceptor Cell Death in Bovine and Primate Retinal Primary Cell CultureInvestigative Ophthalmology & Visual Science, 2006